We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$67.6B
AUM Growth
+$1.06B
Cap. Flow
-$786M
Cap. Flow %
-1.16%
Top 10 Hldgs %
10.48%
Holding
4,032
New
548
Increased
1,485
Reduced
1,480
Closed
497

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$191M
2
NKE icon
Nike
NKE
+$190M
3
UNH icon
UnitedHealth
UNH
+$158M
4
SHOP icon
Shopify
SHOP
+$153M
5
TSM icon
TSMC
TSM
+$151M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$910M
2
MSFT icon
Microsoft
MSFT
+$668M
3
META icon
Meta Platforms (Facebook)
META
+$351M
4
MU icon
Micron Technology
MU
+$244M
5
AAPL icon
Apple
AAPL
+$191M

Sector Composition

Rank Sector Weight
1 Technology 20.86%
2 Healthcare 15.8%
3 Consumer Discretionary 14.09%
4 Financials 8.97%
5 Industrials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
276
Supernus Pharmaceuticals
SUPN
$2.75B
$57.8M 0.09%
1,598,722
-129,900
-8% -$4.57M
TSN icon
277
Tyson Foods
TSN
$19.7B
$57.1M 0.08%
993,714
-148,186
-13% -$8.95M
CCOI icon
278
Cogent Communications
CCOI
$559M
$57M 0.08%
739,756
-155,400
-17% -$12.4M
KMX icon
279
CarMax
KMX
$8.15B
$56.9M 0.08%
695,900
+362,300
+109% +$28.5M
COKE icon
280
Coca-Cola Consolidated
COKE
$12.1B
$56.7M 0.08%
450,270
+26,000
+6% +$3.26M
RMD icon
281
ResMed
RMD
$32.2B
$56.6M 0.08%
247,700
+163,700
+195% +$39.4M
FTS icon
282
Fortis
FTS
$28.7B
$56.5M 0.08%
1,358,652
-89,100
-6% -$3.9M
CPRX
283
DELISTED
Catalyst Pharmaceutical
CPRX
$56.5M 0.08%
2,706,116
+180,100
+7% +$3.87M
BKE icon
284
Buckle
BKE
$2.35B
$55.9M 0.08%
1,100,002
-15,100
-1% -$714K
BDX icon
285
Becton Dickinson
BDX
$48.7B
$55.8M 0.08%
245,991
-427,100
-63% -$98.6M
SWK icon
286
Stanley Black & Decker
SWK
$15.6B
$55.7M 0.08%
693,362
+147,600
+27% +$13.7M
DE icon
287
Deere & Co
DE
$166B
$55.5M 0.08%
+130,900
New +$55.1M
FRSH icon
288
Freshworks
FRSH
$3.22B
$55.5M 0.08%
3,429,366
+293,266
+9% +$4.17M
THC icon
289
Tenet Healthcare
THC
$20.9B
$55.4M 0.08%
438,563
+373,988
+579% +$55.6M
WDFC icon
290
WD-40
WDFC
$3.12B
$55.2M 0.08%
227,661
+2,300
+1% +$613K
COF icon
291
Capital One
COF
$134B
$55.1M 0.08%
308,899
+57,005
+23% +$9.87M
PHI icon
292
PLDT
PHI
$4.21B
$54.7M 0.08%
2,468,268
-72,393
-3% -$1.72M
LBTYA icon
293
Liberty Global Class A
LBTYA
$3.49B
$54.4M 0.08%
4,264,267
-728,885
-15% -$12.2M
WDC icon
294
Western Digital
WDC
$160B
$54.4M 0.08%
1,206,752
-404,970
-25% -$20.4M
ITUB icon
295
Itaú Unibanco
ITUB
$81.7B
$54.3M 0.08%
12,412,782
+5,318,645
+75% +$27.4M
STNG icon
296
Scorpio Tankers
STNG
$3.76B
$54.3M 0.08%
1,092,515
-239,500
-18% -$13.7M
MZTI
297
The Marzetti Company
MZTI
$3.11B
$54.1M 0.08%
312,718
-31,662
-9% -$5.8M
BSV icon
298
Vanguard Short-Term Bond ETF
BSV
$45.6B
$53.8M 0.08%
696,900
+143,500
+26% +$11.1M
NTAP icon
299
NetApp
NTAP
$39.4B
$53.2M 0.08%
458,380
-379,032
-45% -$46.3M
SPSB icon
300
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
$53.1M 0.08%
1,778,300
-371,700
-17% -$11.1M

Similar funds

Jim Simons's Q4 2024 Portfolio in Review

As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
  • Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
  • Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
  • Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
  • Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
  • Jim Simons opened 548 new positions and closed 497 in Q4 2024.
  • Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.